- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04063670
Coping After Pediatric Scoliosis Surgery (CAPS)
Coping After Pediatric Scoliosis Surgery: How Does it Affect Pain and Function?
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94158
- University of California, San Francisco
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- All children ages 11 to 18 years old treated with primary multilevel spinal surgery of any approach
Exclusion Criteria:
- Non-English speaking
- Non-idiopathic scoliosis, such as neuromuscular, congenital or syndromic.
- Other comorbidity, including developmental delay.
- Any surgical complication that results in significant divergence from our institution's standard scoliosis pathway.
- Unplanned admission within 6 weeks of index operation.
- Active treatment psychotherapy and/or cognitive behavioral therapy for any reason
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Control
Routine, standard-of-care treatment
|
Routine, Standard-of-Care
|
EXPERIMENTAL: Video Intervention
Routine, standard-of-care PLUS peri-operative video series
|
Peri-operative video series focusing on expanded education and coping skills before and after scoliosis surgery for adolescent idiopathic scoliosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-Operative Pain
Time Frame: Up to 6-weeks post-operatively
|
Outcome #1 will evaluate the intervention's impact on post-operative pain via completion of the computer-adaptive NIH PROMIS measures on pain intensity and pain behavior. For each of the PROMIS measures, a score of 50 is the average for the United States general population with a standard deviation of 10. All scores are converted to T-scores. The T-score and standard error are automatically reported after completion of the computer-adaptive test. A higher PROMIS T-score represents more of the concept being measured. As each patient will have a pre-operative baseline score, the difference between pre- and post-operative scores will be utilized for all further analysis, with a difference of 10 points (1-standard deviation) scored as the minimal clinically significant difference. |
Up to 6-weeks post-operatively
|
Post-Operative Pain
Time Frame: Up to 6-weeks post-operatively
|
Outcome #2 will evaluate the intervention's impact on a proxy for post-operative pain via completion of a 1-question survey on recent opioid consumption.
The question is formatted as a 5-point Likert scale, scored 1-5, with higher scores indicating more frequent opioid consumption.
|
Up to 6-weeks post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Reported Outcomes - Global Health
Time Frame: Up to 6-weeks post-operatively
|
Outcome #3 will measure patient reported outcomes via administration of the computer adaptive NIH PROMIS measures for global health. For each of the PROMIS measures, a score of 50 is the average for the United States general population with a standard deviation of 10. All scores for this measure will be converted to T-scores via the NIH's published guidelines. As each patient will have a pre-operative baseline score, the difference between pre- and post-operative scores will be utilized for all further analysis, with a difference of 10 points (1-standard deviation) scored as the minimal clinically significant difference. |
Up to 6-weeks post-operatively
|
Patient Reported Outcomes - Mobility
Time Frame: Up to 6-weeks post-operatively
|
Outcome #4 will measure patient reported outcomes and functional status via completion of the computer-adaptive NIH PROMIS measure for mobility For each of the PROMIS measures, a score of 50 is the average for the United States general population with a standard deviation of 10. All scores are converted to T-scores. The T-score and standard error are automatically reported after completion of the computer-adaptive test. A higher PROMIS T-score represents more of the concept being measured. As each patient will have a pre-operative baseline score, the difference between pre- and post-operative scores will be utilized for all further analysis, with a difference of 10 points (1-standard deviation) scored as the minimal clinically significant difference. |
Up to 6-weeks post-operatively
|
Patient Reported Outcomes - Positive Affect
Time Frame: Up to 6-weeks post-operatively
|
Outcome #5 will measure patient reported outcomes via completion of the computer-adaptive NIH PROMIS measure for positive affect. For each of the PROMIS measures, a score of 50 is the average for the United States general population with a standard deviation of 10. All scores are converted to T-scores. The T-score and standard error are automatically reported after completion of the computer-adaptive test. A higher PROMIS T-score represents more of the concept being measured. As each patient will have a pre-operative baseline score, the difference between pre- and post-operative scores will be utilized for all further analysis, with a difference of 10 points (1-standard deviation) scored as the minimal clinically significant difference. |
Up to 6-weeks post-operatively
|
Patient Reported Outcomes - Physical Activity
Time Frame: Up to 6-weeks post-operatively
|
Outcome #6 will measure patient reported outcomes and functional status via completion of the computer-adaptive NIH PROMIS measure for physical activity. For each of the PROMIS measures, a score of 50 is the average for the United States general population with a standard deviation of 10. All scores are converted to T-scores. The T-score and standard error are automatically reported after completion of the computer-adaptive test. A higher PROMIS T-score represents more of the concept being measured. As each patient will have a pre-operative baseline score, the difference between pre- and post-operative scores will be utilized for all further analysis, with a difference of 10 points (1-standard deviation) scored as the minimal clinically significant difference. |
Up to 6-weeks post-operatively
|
Patient Reported Outcomes - Strength Impact
Time Frame: Up to 6-weeks post-operatively
|
Outcome #7 will measure patient reported outcomes and functional status via completion of the computer-adaptive NIH PROMIS measure for strength impact. For each of the PROMIS measures, a score of 50 is the average for the United States general population with a standard deviation of 10. All scores are converted to T-scores. The T-score and standard error are automatically reported after completion of the computer-adaptive test. A higher PROMIS T-score represents more of the concept being measured. As each patient will have a pre-operative baseline score, the difference between pre- and post-operative scores will be utilized for all further analysis, with a difference of 10 points (1-standard deviation) scored as the minimal clinically significant difference. |
Up to 6-weeks post-operatively
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain-Related Disability and Post-Operative Functional Status.
Time Frame: Up to 6-weeks post-operatively
|
Outcome #8 will measure post-operative functional status via a 5-question survey on the following activities: sleeping through the night without awaking for pain medication, walking outside the house, showering and dressing independently, patient return to school and parent return to work.
Each of these questions was selected as a proxy for improved functional status.
Each question is answered 'Yes' or 'No", and graded '1' or '0', respectively.
A higher score represents improved functional status.
Each of these questionnaires will be administered on a weekly basis.
|
Up to 6-weeks post-operatively
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mohammad Diab, MD, UCSF Department of Orthopaedic Surgery
- Principal Investigator: Alex Gornitzky, MD, UCSF Department of Orthopaedic Surgery
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-26617
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent Idiopathic Scoliosis
-
Cairo UniversityRecruitingScoliosis Idiopathic | Adolescent Idiopathic ScoliosisEgypt
-
Spino Modulation Inc.TerminatedAdolescent Idiopathic Scoliosis | Juvenile Idiopathic ScoliosisCanada
-
Medtronic Spinal and BiologicsMedical College of Wisconsin; Syntactx; Exponent, Inc.; Medical Metrics Diagnostics...Active, not recruitingAdolescent Idiopathic Scoliosis | Juvenile Idiopathic ScoliosisUnited States, Canada, United Kingdom
-
Dr. Casey Stondell, MDPacira Pharmaceuticals, IncRecruitingAdolescent Idiopathic Scoliosis | Juvenile Idiopathic ScoliosisUnited States
-
The University of Hong KongActive, not recruitingScoliosis | Adolescent Idiopathic Scoliosis | Idiopathic ScoliosisHong Kong
-
Istanbul Medipol University HospitalRecruitingAdolescent Idiopathic ScoliosisTurkey
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
Istanbul UniversityRecruitingAdolescent Idiopathic ScoliosisTurkey
-
Johns Hopkins UniversityRecruitingDysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic ScoliosisAdolescent Idiopathic ScoliosisUnited States
-
The Hong Kong Polytechnic UniversityWashington University School of Medicine; The University of Hong KongRecruitingAdolescent Idiopathic ScoliosisHong Kong
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted